Furthermore, UBE2O enhances the migratory and invasive properties of ccRCC cells through cytoskeletal reorganization and the modulation of adhesion molecules, including the downregulation of E-cadherin. Here, UBE2O is linked to nonpapillary renal cell carcinoma.